Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?
about
Parkinson's disease proteins: Novel mitochondrial targets for cardioprotectionStroke and idiopathic Parkinson's disease: does a shortage of dopamine offer protection against stroke?Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study.Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease.Estimated life expectancy of Parkinson's patients compared with the UK population.Mortality in Iranian Patients with Parkinson's Disease: Cumulative Impact of Cardiovascular Comorbidities as One Major Risk FactorNeurologist-associated reduction in PD-related hospitalizations and health care expendituresParkinson's disease between internal medicine and neurologyParkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarctionEvaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatmentAtypical cancer pattern in patients with Parkinson's disease.Predictors of survival in patients with Parkinson disease.Further evidence of increased risk of mortality of Parkinson's disease.How far are we in understanding the cause of Parkinson's disease?Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.Prospective cohort study of type 2 diabetes and the risk of Parkinson's diseaseRole of homocysteine in the treatment of Parkinson's disease.Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosisSkin cancer and Parkinson's disease.How should we treat a patient with early Parkinson's disease?Motor complications, levodopa metabolism and progression of Parkinson's disease.Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease.Age-dependent metabolic dysregulation in cancer and Alzheimer's disease.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?Influence of left versus right hemibody onset Parkinson's disease on cardiovascular control.Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.Parkinson's disease and cerebrovascular disease: is there a link? A neurosonological case-control study.Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson's disease.The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is not associated with Parkinson's diseaseUsing monoamine oxidase type B inhibitors in Parkinson's disease.Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes.Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preferencePossible treatment concepts for the levodopa-related hyperhomocysteinemia.The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up).Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases.Parkinson's disease and the risk of cerebrovascular pathology.Small-vessel disease in patients with Parkinson's disease: a clinicopathological study.Prevalence of stroke in Parkinson's disease: a postmortem study.
P2860
Q26781796-A34106A6-D569-42F7-9975-D56BBB240746Q32052206-4BEE4D30-F07E-429B-8F0A-CAE8B3A1F693Q33735302-14BD71AA-1C85-4FC8-83A7-66CB9A702747Q34983826-D155C98C-D948-4F3E-AC44-B400F4CC5388Q35719609-D6C32F74-296B-4D4C-BEAD-AF53F762AB8BQ36172639-2BAC0F78-962A-4839-A2B9-3D96B66D2B1EQ36242256-E24E5E57-0BD9-4CF4-9128-0C4E9E062735Q36330887-62C762A4-5B7C-443E-9906-EF1A1A6D2DEFQ36464243-D9F69AE2-8B44-47F6-9D1F-8AFE9E09DE7AQ36526385-C16CB7FF-8EEA-4445-8CF6-ED80F5371678Q36578455-201F74D6-E12D-485E-B893-F00990E5A5B5Q36615809-CBF60DC0-8D9C-4256-9983-F0E37B431331Q36690717-0B9DFD2B-CD50-4A69-8FB8-98BE00BDA3FAQ36892192-90C63BE9-7232-4226-8FB9-F4489E8884FCQ36893823-B53C5B11-A2DC-4103-9BCF-D20D653E1A03Q36897560-05D1C9BF-3601-4F1C-87C8-F63395908C9EQ36906241-244D54CB-31D9-431F-A78A-C75F95087D61Q37174063-41D050C3-A711-4BA0-931C-05FE97DCA79FQ37198492-C9AB0DC8-43C8-4161-B0F5-50B257B83DFBQ37671764-A1CBEFA5-E628-4AF1-8863-950A57FF8B0DQ37775098-3C18CBD4-682A-4B3F-9005-A1E93E9CD7A7Q37863681-9855A2E0-9B53-4A23-A22A-65C0EF411622Q38112217-590CC522-95E3-48A9-9980-A8EBB0009FD1Q38259091-88BE93B7-82AE-4BBC-803A-7DC7B7E8569FQ38951947-245CD247-96B1-4B89-8A1C-993BD47EFABFQ39889917-78DF3E40-5AE5-43A9-9FDB-5D1B5423003CQ40294542-8553E230-DB19-4AD3-9490-B16596272B5FQ40659962-D8CBFA90-F1EF-43BC-A594-A4AC7035B735Q41203349-EBD0F4B5-CF52-4E63-9A04-629042E352A1Q42181463-5BA724E0-66D0-4FF6-9655-FF2AAA3B838EQ42395722-C47FBB6B-582B-4C92-8449-74355A05EE2BQ42427666-847ED193-4FEF-4A32-B16E-A05E0A46C873Q42545608-50351DCA-73AC-47B4-81A4-AB70FF466078Q42642958-05C59735-ABAE-433F-9E03-5D618621A3DBQ42952317-AB33D926-D607-4B66-A24B-E33DBAFB873EQ44105053-3911B945-544D-44BD-8FBA-C55FEFA0CBC6Q48224650-B2250B29-5C0C-4A0C-9A2F-FA153DF3C4AFQ48351693-05748759-74A7-47A2-8C35-17ED2B4967C5Q48361804-121752B3-3CD9-48FB-ACE3-A94C128AA8A9Q48494065-3BF44736-95EB-47C4-AD71-85AE0D0FDF58
P2860
Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Survival and cause of death in ...... : possible clues to aetiology?
@ast
Survival and cause of death in ...... : possible clues to aetiology?
@en
type
label
Survival and cause of death in ...... : possible clues to aetiology?
@ast
Survival and cause of death in ...... : possible clues to aetiology?
@en
prefLabel
Survival and cause of death in ...... : possible clues to aetiology?
@ast
Survival and cause of death in ...... : possible clues to aetiology?
@en
P2860
P356
P1476
Survival and cause of death in ...... : possible clues to aetiology?
@en
P2093
Y Ben-Shlomo
P2860
P304
P356
10.1136/JNNP.58.3.293
P407
P577
1995-03-01T00:00:00Z